154 related articles for article (PubMed ID: 36383629)
41. Clinical value of GRACE score combined with DFR in predicting short-term prognosis of patients undergoing early PCI after thrombolysis for acute myocardial infarction.
Liu F; Liu XJ; He YP; Liu GB; Lan T; Ye JS
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4038-4045. PubMed ID: 37203827
[TBL] [Abstract][Full Text] [Related]
42. Walking beyond the GRACE (Global Registry of Acute Coronary Events) model in the death risk stratification during hospitalization in patients with acute coronary syndrome: what do the AR-G (ACTION [Acute Coronary Treatment and Intervention Outcomes Network] Registry and GWTG [Get With the Guidelines] Database), NCDR (National Cardiovascular Data Registry), and EuroHeart Risk Scores Provide?
Raposeiras-Roubín S; Abu-Assi E; Cabanas-Grandío P; Agra-Bermejo RM; Gestal-Romarí S; Pereira-López E; Fandiño-Vaquero R; Álvarez-Álvarez B; Cambeiro C; Rodríguez-Cordero M; Lear P; Martínez-Monzonís A; Peña-Gil C; García-Acuña JM; González-Juanatey JR
JACC Cardiovasc Interv; 2012 Nov; 5(11):1117-25. PubMed ID: 23174635
[TBL] [Abstract][Full Text] [Related]
43. Prognostic value of the GRACE discharge score for predicting the mortality of patients with stable coronary artery disease who underwent percutaneous coronary intervention.
Zhao X; Li J; Xian Y; Chen J; Gao Z; Qiao S; Yang Y; Gao R; Xu B; Yuan J
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():550-557. PubMed ID: 31922352
[TBL] [Abstract][Full Text] [Related]
44. Improving risk stratification in non-ST-segment elevation myocardial infarction with combined assessment of GRACE and CRUSADE risk scores.
Paiva L; Providência R; Barra SN; Dinis P; Faustino AC; Costa M; Gonçalves L
Arch Cardiovasc Dis; 2014 Dec; 107(12):681-9. PubMed ID: 25219759
[TBL] [Abstract][Full Text] [Related]
45. Clinical effectiveness of the systematic use of the GRACE scoring system (in addition to clinical assessment) for ischaemic outcomes and bleeding complications in the management of NSTEMI compared with clinical assessment alone: a prospective study.
Guenancia C; Stamboul K; Hachet O; Yameogo V; Garnier F; Gudjoncik A; Cottin Y; Lorgis L
Heart Vessels; 2016 Jun; 31(6):897-906. PubMed ID: 26047775
[TBL] [Abstract][Full Text] [Related]
46. Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.
Widera C; Pencina MJ; Meisner A; Kempf T; Bethmann K; Marquardt I; Katus HA; Giannitsis E; Wollert KC
Eur Heart J; 2012 May; 33(9):1095-104. PubMed ID: 22199121
[TBL] [Abstract][Full Text] [Related]
47. Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
Zhao N; Mi L; Liu X; Pan S; Xu J; Xia D; Liu Z; Zhang Y; Xiang Y; Yuan Z; Guan G; Wang J
PLoS One; 2015; 10(10):e0140532. PubMed ID: 26468876
[TBL] [Abstract][Full Text] [Related]
48. Machine learning for prediction of 30-day mortality after ST elevation myocardial infraction: An Acute Coronary Syndrome Israeli Survey data mining study.
Shouval R; Hadanny A; Shlomo N; Iakobishvili Z; Unger R; Zahger D; Alcalai R; Atar S; Gottlieb S; Matetzky S; Goldenberg I; Beigel R
Int J Cardiol; 2017 Nov; 246():7-13. PubMed ID: 28867023
[TBL] [Abstract][Full Text] [Related]
49. Survival benefit from recent changes in management of men and women with ST-segment elevation myocardial infarction treated with percutaneous coronary interventions.
Zandecki Ł; Sadowski M; Janion M; Kurzawski J; Gierlotka M; Poloński L; Gąsior M
Cardiol J; 2019; 26(5):459-468. PubMed ID: 29924379
[TBL] [Abstract][Full Text] [Related]
50. Addition of TyG index to the GRACE score improves prediction of adverse cardiovascular outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: A retrospective study.
Pang S; Miao G; Zhou Y; Du Y; Rui Z; Zhao X
Front Cardiovasc Med; 2022; 9():957626. PubMed ID: 36093151
[TBL] [Abstract][Full Text] [Related]
51. Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.
Bai XF; Zhang YP; Zhou J; Wu Y; Li RF; Sun LZ; Ma QQ; Lou BW; Zhai BW; Liu MP; Cheng LL; Tong XN; Yuan ZY
Thromb Res; 2018 Oct; 170():142-147. PubMed ID: 30193195
[TBL] [Abstract][Full Text] [Related]
52. Validation of National Cardiovascular Data Registry risk models for mortality, bleeding and acute kidney injury in interventional cardiology at a German Heart Center.
Wolff G; Lin Y; Quade J; Bader S; Kosejian L; Brockmeyer M; Karathanos A; Parco C; Krieger T; Heinen Y; Perings S; Albert A; Icks A; Kelm M; Schulze V
Clin Res Cardiol; 2020 Feb; 109(2):235-245. PubMed ID: 31236693
[TBL] [Abstract][Full Text] [Related]
53. Anaemia to predict outcome in patients with acute coronary syndromes.
Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
[TBL] [Abstract][Full Text] [Related]
54. Prognostic Value of Pre-Infarction Angina Combined with Mean Platelet Volume to Lymphocyte Count Ratio for No-Reflow and Short-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
Chen X; Meng Y; Shao M; Zhang T; Han L; Zhang W; Zhang H; Hai H; Li G
Med Sci Monit; 2020 Jan; 26():e919300. PubMed ID: 31949123
[TBL] [Abstract][Full Text] [Related]
55. Current characteristics and management of ST elevation and non-ST elevation myocardial infarction in the Tokyo metropolitan area: from the Tokyo CCU network registered cohort.
Miyachi H; Takagi A; Miyauchi K; Yamasaki M; Tanaka H; Yoshikawa M; Saji M; Suzuki M; Yamamoto T; Shimizu W; Nagao K; Takayama M
Heart Vessels; 2016 Nov; 31(11):1740-1751. PubMed ID: 26758733
[TBL] [Abstract][Full Text] [Related]
56. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI.
Méndez-Eirín E; Flores-Ríos X; García-López F; Pérez-Pérez AJ; Estévez-Loureiro R; Piñón-Esteban P; Aldama-López G; Salgado-Fernández J; Calviño-Santos RA; Vázquez Rodríguez JM; Vázquez-González N; Castro-Beiras A
Rev Esp Cardiol (Engl Ed); 2012 Mar; 65(3):227-33. PubMed ID: 22281285
[TBL] [Abstract][Full Text] [Related]
57. Comparison of prognostic significance of mean platelet volume/platelet count with GRACE for long-term prognosis in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
Yu T; Dong Y; Sun Z; Sun Z
Int J Cardiol; 2017 Feb; 228():335-340. PubMed ID: 27866024
[TBL] [Abstract][Full Text] [Related]
58. Prognostic impact of the SYNTAX score II in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: analysis of a four-year all-comers registry.
Cid Alvarez AB; Gomez-Peña F; Redondo-Dieguez A; Avila A; López D; Sanmartin X; González-Juanatey JR; Trillo-Nouche R
EuroIntervention; 2019 Oct; 15(9):e796-e803. PubMed ID: 30175963
[TBL] [Abstract][Full Text] [Related]
59. Prognostic impact of residual SYNTAX score in patients with ST-elevation myocardial infarction and multivessel disease: Analysis of an 8-year all-comers registry.
Braga CG; Cid-Alvarez AB; Diéguez AR; Alvarez BA; Otero DL; Sánchez RO; Pena XS; Salvado VG; Trillo-Nouche R; González-Juanatey JR
Int J Cardiol; 2017 Sep; 243():21-26. PubMed ID: 28532984
[TBL] [Abstract][Full Text] [Related]
60. Evaluation of a risk index for predicting short-term and long-term outcomes in patients with ST-elevation myocardial infarction.
Shao C; Wang J; Li P; Yang J; Wang W; Wang Y; Zhao Y; Ni L; Tian J; Zhang K; Gao J; Tang YD; Yang Y
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():542-549. PubMed ID: 31922355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
